The biology of Hodgkin's lymphoma
- PMID: 19078975
- DOI: 10.1038/nrc2542
The biology of Hodgkin's lymphoma
Abstract
Hodgkin's lymphoma was first described in 1832. The aetiology of this lymphoma, however, remained enigmatic for a long time. Only within the past 10 years has the B-cell nature of the pathognomonic Hodgkin and Reed-Sternberg (HRS) cells been revealed, along with several recurrent genetic lesions. The pathogenetic role for Epstein-Barr virus infection has also been substantiated. HRS cells in classical Hodgkin's lymphoma have several characteristics that are unusual for lymphoid tumour cells, and the Hodgkin's lymphoma microenvironment is dominated by an extensive mixed, potentially inflammatory cellular infiltrate. Understanding the contribution of all of these changes to the pathogenesis of this disease is essential for the development of novel therapies.
Similar articles
-
Molecular biology of Hodgkin lymphoma.Hematology Am Soc Hematol Educ Program. 2009:491-6. doi: 10.1182/asheducation-2009.1.491. Hematology Am Soc Hematol Educ Program. 2009. PMID: 20008234 Review.
-
Hodgkin and Reed-Sternberg-like cells in B-cell chronic lymphocytic leukemia represent the outgrowth of single germinal-center B-cell-derived clones: potential precursors of Hodgkin and Reed-Sternberg cells in Hodgkin's disease.Blood. 2000 Feb 1;95(3):1023-31. Blood. 2000. PMID: 10648418
-
Hodgkin lymphoma.J Clin Invest. 2012 Oct;122(10):3439-47. doi: 10.1172/JCI61245. Epub 2012 Oct 1. J Clin Invest. 2012. PMID: 23023715 Free PMC article. Review.
-
Suppression of the LMP2A target gene, EGR-1, protects Hodgkin's lymphoma cells from entry to the EBV lytic cycle.J Pathol. 2013 Aug;230(4):399-409. doi: 10.1002/path.4198. J Pathol. 2013. PMID: 23592216
-
Human immunodeficiency virus-associated Hodgkin's disease derives from post-germinal center B cells.Blood. 1999 Apr 1;93(7):2319-26. Blood. 1999. PMID: 10090942
Cited by
-
The Impact of KIR Polymorphism on the Risk of Developing Cancer: Not as Strong as Imagined?Front Genet. 2016 Jun 28;7:121. doi: 10.3389/fgene.2016.00121. eCollection 2016. Front Genet. 2016. PMID: 27446203 Free PMC article. Review.
-
Ipilimumab, nivolumab, and brentuximab vedotin combination therapies in patients with relapsed or refractory Hodgkin lymphoma: phase 1 results of an open-label, multicentre, phase 1/2 trial.Lancet Haematol. 2020 Sep;7(9):e660-e670. doi: 10.1016/S2352-3026(20)30221-0. Lancet Haematol. 2020. PMID: 32853585 Free PMC article. Clinical Trial.
-
New strategies in Hodgkin lymphoma: better risk profiling and novel treatments.Clin Cancer Res. 2013 Jun 1;19(11):2797-803. doi: 10.1158/1078-0432.CCR-12-3064. Epub 2013 Feb 27. Clin Cancer Res. 2013. PMID: 23447000 Free PMC article. Review.
-
LMP1 mediates multinuclearity through downregulation of shelterin proteins and formation of telomeric aggregates.Blood. 2015 Mar 26;125(13):2101-10. doi: 10.1182/blood-2014-08-594176. Epub 2015 Jan 7. Blood. 2015. PMID: 25568351 Free PMC article.
-
Deciphering the Genetic Complexity of Classical Hodgkin Lymphoma: Insights and Effective Strategies.Curr Genomics. 2024;25(5):334-342. doi: 10.2174/0113892029301904240513045755. Epub 2024 May 24. Curr Genomics. 2024. PMID: 39323623 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous